Browse

Monitoring of transtubular potassium gradient in the diuretic management of patients with cirrhosis and ascites

DC Field Value Language
dc.contributor.authorLim, Young-Suk-
dc.contributor.authorHan, Jin Suk-
dc.contributor.authorKim, Kyung-Ah-
dc.contributor.authorYoon, Jung-Hwan-
dc.contributor.authorKim, Chung Yong-
dc.contributor.authorLee, Hyo-Suk-
dc.date.accessioned2009-11-04T07:26:02Z-
dc.date.available2009-11-04T07:26:02Z-
dc.date.issued2002-
dc.identifier.citationLiver 2002; 22: 426-32en
dc.identifier.issn0106-9543 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12390478-
dc.identifier.urihttps://hdl.handle.net/10371/11135-
dc.description.abstractBACKGROUND/AIMS: Aldosterone antagonists are the diuretics of first choice in the treatment of cirrhotic ascites. However, there is still no reliable clinical parameter to evaluate their efficacy. Transtubular potassium gradient (TTKG), the accurate indicator of aldosterone bioactivity, may serve as a guide for the proper use of the aldosterone antagonists. METHODS: In 23 patients with cirrhotic ascites, the daily administered initial dosage of 100 mg of spironolactone was increased by 100 mg/day at intervals of 5 days until either diuresis commenced or TTKG fell below 3.0, the value indicating complete blockade of aldosterone bioactivity. For the non-responders with TTKG lower than 3.0, furosemide was given in addition to spironolactone. RESULTS: Basal TTKG correlated significantly with plasma aldosterone concentration (r = 0.60, P = 0.002). Spironolactone induced the decrease of TTKG in 20 patients, from 5.3 +/- 0.5 to 2.9 +/- 0.2 (mean +/- SE, P < 0.001). A TTKG value of 3.0 could classify seven patients, who did not respond to low dose spironolactone, into two distinct groups at that time, indicating different further diuretic regimen. All patients achieved diuretic responses without complication by this TTKG-guided modification of diuretics. CONCLUSIONS: TTKG may be a suitable guide for the diuretic management of cirrhotic ascites by accurately reflecting the effect of aldosterone antagonists.en
dc.language.isoen-
dc.publisherBlackwell Munksgaarden
dc.subjectAldosterone Antagonists/*therapeutic useen
dc.subjectDiuretics/*therapeutic useen
dc.subjectDrug Therapy, Combinationen
dc.subjectFibrosis/*drug therapy/metabolismen
dc.subjectFurosemide/therapeutic useen
dc.subjectKidney Tubules/drug effects/*metabolismen
dc.subjectMonitoring, Physiologic/*methodsen
dc.subjectPotassium/*metabolismen
dc.subjectSpironolactone/therapeutic useen
dc.titleMonitoring of transtubular potassium gradient in the diuretic management of patients with cirrhosis and ascitesen
dc.typeArticleen
dc.contributor.AlternativeAuthor임영석-
dc.contributor.AlternativeAuthor한진석-
dc.contributor.AlternativeAuthor김경아-
dc.contributor.AlternativeAuthor윤정환-
dc.contributor.AlternativeAuthor김정용-
dc.contributor.AlternativeAuthor이효석-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse